All Stories

  1. Decoding the cognitive profile of fibromyalgia: interactions among psychiatric symptoms, personality traits, and quality of life
  2. Tracking the invisible: Impact of disease-modifying therapies on serum neurofilament light chain and clinical outcomes in treatment-naïve multiple sclerosis
  3. The many faces of Wilson disease: a contemporary review of neuropsychiatric presentations, diagnostic challenges, and treatment paradigms
  4. Cognitive and emotional factors relation to treatment adherence in asthmatic patients in upper Egypt
  5. Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study
  6. APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
  7. Peripheral auditory function in Parkinson’s disease: findings from a pilot case-control study
  8. Platinum and Taxane-Induced Neuropathy and Its Impact on Quality of Life: A Single Institution Study.
  9. Mutations in the Key Autophagy Tethering Factor EPG5 Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism
  10. Nerve ultrasound as an adjunct to nerve conduction studies in Guillain–Barré syndrome diagnosis: a prospective Egyptian case–control study
  11. APOE, Sex, and Alzheimer’s Disease: Investigating Their Interplay in the Egyptian Population
  12. Sleep disorders in a sample of Egyptian patients with Parkinson's disease: a case–control polysomnography study
  13. APOE genetic variability in an Egyptian cohort of PD
  14. Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis
  15. Correction: Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study
  16. Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study
  17. Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum
  18. In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial
  19. Effects of transcranial magnetic stimulation on sleep quality in fibromyalgia: A double-blind randomized clinical trial
  20. Mechanical thrombectomy of acute ischemic stroke of Medium Sized Vessels (M2 segment of middle cerebral artery occlusion)
  21. The impact of sex differences on stroke risk factors and 3-month outcomes in patients receiving thrombolytic therapy for acute ischemic stroke
  22. Impact of COVID-19 pandemic on the care of people with epilepsy and predictors of epilepsy worsening: Aswan/upper Egypt hospital-based study
  23. The Impact of Sex Differences on Stroke Risk Factors and 3-Month Outcomes in Patients Receiving Thrombolytic Therapy for Acute Ischemic Stroke
  24. Prevalence and determinants of post-stroke psychosis in Aswan: a prospective study
  25. Case report: Avoidant/restrictive food intake disorder after tonsillectomy
  26. Mutations in EPG5 are associated with a wide spectrum of neurodevelopmental and neurodegenerative disorders
  27. Impact of COVID-19 Pandemic on the Care of People with Epilepsy and Predictors of Epilepsy Worsening: Aswan/Upper Egypt Hospital-based study
  28. Short-Term Therapeutic Effect of Repetitive Transcranial Magnetic Stimulations of Sleep Disorders in Parkinson’s Disease: A Randomized Clinical Trial (Pilot Study)
  29. Determining Optimal Cut-Off Value For Ultrasound-Measured Median Nerve Cross-Sectional Area For Diagnosis Of Carpal Tunnel Syndrome In A Sample Of Egyptian Population
  30. Impact of COVID-19 Pandemic on Patients with Tension-Type Headache
  31. The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
  32. Biallelic variation in the choline and ethanolamine transporterFLVCR1underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders
  33. The role of infections and inflammation in schizophrenia: review of the evidence
  34. Bridging the gap: associations between gut microbiota and psychiatric disorders
  35. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial
  36. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study
  37. Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
  38. Cerebrovascular reactivity after functional activation of the Brain using Photic Stimulation in Migraine and Tension Type Headache: a transcranial doppler Ultrasonography Study
  39. Myasthenia gravis with achalasia secondary to thymoma: a case report and literature review
  40. Relationship Between Disability and Psychiatric Outcome in Multiple Sclerosis Patients and Its Determinants
  41. Effets de la stimulation transcrânienne à courant direct sur la douleur et la consommation d’opioïdes après une chirurgie de la colonne vertébrale
  42. Effects of transcranial direct current stimulation in pain and opioid consumption after spine surgery
  43. Relationship between Attention Deficit Hyperactivity Disorder and epilepsy: a literature review
  44. Erratum to: Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia
  45. Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia
  46. Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
  47. Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes
  48. Genetic and phenotypic characterization of NKX6‐2‐related spastic ataxia and hypomyelination
  49. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
  50. PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation
  51. An update on advances in magnetic resonance imaging of multiple system atrophy
  52. Clinical and Genetic analysis of Egyptian hereditary spastic paraplegia using next generation sequencing
  53. Genotype‐phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14
  54. Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset
  55. Severe axonal neuropathy is a late manifestation of SPG11
  56. Genetic and phenotypic characterization of complex hereditary spastic paraplegia